Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care evaluation by...
Nursing Evaluation01:15

Nursing Evaluation

The evaluation stage signals the end of the nursing process. The nurse gathers evaluative data to assess whether or not the patient has attained the expected results. Whereas the nurse collects data in the nursing assessment to identify the patient's health concerns, the evaluation stage data determines if the indicated health issues are resolved. Evaluative data collection includes two sections: the data acquired to evaluate patient outcomes and the time criteria for data collection.
Section...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MEDiastinal Irradiation and CArdio-Toxic Effects (MEDICATE): Exploring the Relationship between Cardiac Irradiation and High Sensitivity Troponins.

Clinical oncology (Royal College of Radiologists (Great Britain))ยท2019
Same author

Canadian integrative oncology research priorities: results of a consensus-building process.

Current oncology (Toronto, Ont.)ยท2013
Same author

Research and regulatory issues for integrative oncology.

Current oncology (Toronto, Ont.)ยท2008
Same author

Integrative oncology: a Canadian and international perspective.

Current oncology (Toronto, Ont.)ยท2008
Same author

The integrative oncology supplement--a paradigm for both patient care and communication.

Current oncology (Toronto, Ont.)ยท2008
Same author

Chinese medicine and biomodulation in cancer patients--Part one.

Current oncology (Toronto, Ont.)ยท2008

Related Experiment Video

Updated: Jul 2, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

How do we evaluate outcome in an integrative oncology program?

S M Sagar1

  • 1Juravinski Cancer Centre, Hamilton, Ontario. stephen.sagar@jcc.hhsc.ca

Current Oncology (Toronto, Ont.)
|September 5, 2008
PubMed
Summary
This summary is machine-generated.

Integrative oncology enhances conventional cancer treatments with complementary therapies to improve patient outcomes and quality of life. Evidence-based programs require continuous evaluation for quality and cost-effectiveness.

Keywords:
Integrativeauditeconomicsmeasurementoncologyoutcomesqualitativequantitativeservices

Related Experiment Videos

Last Updated: Jul 2, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Area of Science:

  • Integrative oncology
  • Complementary therapies
  • Cancer treatment

Background:

  • Integrative oncology utilizes complementary therapies alongside conventional cancer treatments.
  • The goal is to enhance treatment effectiveness and patient well-being.

Purpose of the Study:

  • To outline the principles and evaluation domains for effective integrative oncology programs.
  • To emphasize the importance of evidence-based implementation and continuous quality assessment.

Main Methods:

  • Focus on improving defined outcomes: symptom control, quality of life, rehabilitation, and recurrence prevention.
  • Evaluation of program implementation based on best evidence.
  • Continuous assessment of quality, techniques, data collection, and cost-effectiveness.

Main Results:

  • Integrative oncology aims to improve symptom control and quality of life.
  • Programs should be evaluated for adherence to protocols and individual outcomes.
  • Potential benefits include a whole-systems health approach and economic advantages.

Conclusions:

  • Effective integrative oncology programs require evidence-based implementation and ongoing evaluation.
  • Key domains for assessment include symptom management, quality of life, and cost-effectiveness.
  • A whole-systems approach may offer significant advantages in cancer care.